Discover 2,099 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,099
Active & Responsive
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder
for
Major Depressive Disorder
Location: 24 recruiting locations
Sponsor: Syndeio Biosciences, Inc
Sex: All
Age: 18 - 64
Code: NCT06547489
Phase2, Recruiting
Active & Responsive
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
for
ADHD, Anxiety, Generalized Anxiety, Social Anxiety Disorder
Location: 44 recruiting locations
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All
Age: 18 - 65
Code: NCT06973577
Phase3, Recruiting
Active & Responsive
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
for
AAA, AAA - Abdominal Aortic Aneurysm
Location: 24 recruiting locations
Sponsor: Endologix
Sex: All
Age: 21+
Code: NCT05064540
Recruiting
Active & Responsive
Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)
for
Diabetic Foot Ulcer
Location: 7 recruiting locations
Sponsor: Cellution Biologics
Sex: All
Age: 18+
Code: NCT07014176
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Helix Research Network
for
Genetic Predisposition to Disease, Genetics Disease
Location: 10 recruiting locations
Sponsor: Helix, Inc
Sex: All
Age: 18+
Code: NCT06057181
Recruiting
Active & Responsive
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
for
Carcinoma, Non-Small-Cell Lung
Location: 41 recruiting locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06623422
Phase3, Recruiting
Active & Responsive
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
for
Non-small Cell Lung Cancer, NSCLC
Location: 16 recruiting locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06422143
Phase3, Recruiting
Active & Responsive
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer